The University of Chicago Header Logo

Connection

Rita Nanda to Triazoles

Back to Details
This is a "connection" page, showing publications Rita Nanda has written about Triazoles.
Rita Nanda
Connection Strength
0.025
Triazoles
  1. Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006. J Clin Oncol. 2013 May 10; 31(14):1726-31.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.